Veeva Systems Inc. (VEEV) News
Filter VEEV News Items
VEEV News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VEEV News Highlights
- For VEEV, its 30 day story count is now at 39.
- Over the past 21 days, the trend for VEEV's stories per day has been choppy and unclear. It has oscillated between 1 and 12.
- The most mentioned tickers in articles about VEEV are STAR, BEAT and ESS.
Latest VEEV News From Around the Web
Below are the latest news stories about Veeva Systems Inc that investors may wish to consider to help them evaluate VEEV as an investment opportunity.
3 Beaten-Down Growth Stocks With More Than 50% Upside PotentialThe key to picking growth stocks right now is to look for companies whose earnings momentum and growth can withstand any market conditions. |
Veeva Systems (VEEV) Reports Next Week: Wall Street Expects Earnings GrowthVeeva (VEEV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Veeva Widely Recognized for Leadership and Innovation in Support of Customers and EmployeesVeeva Systems (NYSE: VEEV) has received broad recognition for its innovation, growth, and impact––including its leading 'Work Anywhere' approach and pioneering a path as the first public company to convert to a Public Benefit Corporation (PBC). Among the recent accolades, Veeva was named one of Inc. Magazine's Best-Led Companies, ranked in Fortune's Future 50 for a second year, and placed in the top 30 of its Fastest-Growing Companies list for a fifth year. |
Industry Leaders to Come Together to Advance Digital Trials at Veeva TMF Innovation ForumVeeva Systems (NYSE: VEEV) today announced that leaders from Alexion, Merck & Co., Inc., Takeda, and Seagen will speak at the first-ever Veeva TMF Innovation Forum on March 10, 2022. The one-day online event will bring together more than 250 trial master file (TMF) experts and clinical operations leaders to share best practices for TMF management and discuss advancements toward more connected, digital clinical trials. |
Veeva Systems' (NYSE:VEEV) five-year total shareholder returns outpace the underlying earnings growthVeeva Systems Inc. ( NYSE:VEEV ) shareholders might be concerned after seeing the share price drop 24% in the last... |
10 Software Stocks to Sell Now According to Cathie WoodIn this article, we discuss 10 software stocks to sell now according to Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to 5 Software Stocks to Sell Now According to Cathie Wood. The market correction resulting from a surge in inflation and an imminent rise in interest rates […] |
Veeva Systems (VEEV) Vault CDMS to Aid Idorsia's Clinical TrialsAdoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Veeva Development Cloud business. |
Here's the Next Stock I'm Going to BuyStock market volatility can create great opportunities for long-term investors. The recent growth stock sell-off has produced a handful of attractive valuations, and I'm excited to scoop up some great investments at a discount. The next time I move cash into the market, I'm going to buy more of a tech stock that is set to capitalize on the inevitable growth of the life sciences industry. |
2 Unstoppable Stocks That Are On Sale Right NowTwo stocks I would put in that category today are Veeva Systems (NYSE: VEEV) and Starbucks (NASDAQ: SBUX). Both of these growth stocks are down 9% or more in 2022, but here's why that could be a good thing for investors. Veeva helps companies, particularly in the healthcare industry, digitize their operations and push more of their activities to the cloud. |
2 Growth Stocks I'd Buy Before Shiba InuIt's much easier to predict the future performance of these companies than it is to predict that of Shiba Inu. |